Yu-Cheng Kuo Selected Research

2,3,7,7a- tetrahydro- 3- hydroxy- 7- methyl- 2- (prop- 1- en- 1- yl)- 5H- furo(3,4- b)pyran- 5- one

3/2019

The fungus-derived retinoprotectant theissenolactone C improves glaucoma-like injury mediated by MMP-9 inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu-Cheng Kuo Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 03/2005
13	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 03/2005
4	Breast Neoplasms (Breast Cancer) 01/2021 - 05/2018
3	Neuroinflammatory Diseases 03/2019 - 11/2014
2	Carcinogenesis 10/2021 - 01/2021
2	Colorectal Neoplasms (Colorectal Cancer) 09/2021 - 02/2012
2	Body Weight (Weight, Body) 01/2018 - 01/2018
2	Liver Neoplasms (Liver Cancer) 12/2016 - 04/2014
2	Chronic Hepatitis (Chronic Active Hepatitis) 01/2015 - 03/2005
1	Adenocarcinoma 02/2022
1	Rectal Neoplasms (Rectal Cancer) 02/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Esophageal Squamous Cell Carcinoma 01/2022
1	Infections 01/2022
1	COVID-19 01/2022
1	Cholangiocarcinoma 10/2021
1	Brain Neoplasms (Brain Tumor) 04/2021
1	Body Weight Changes 01/2021
1	Ischemia 03/2019
1	Disease Progression 03/2019
1	Uveitis 03/2019
1	Glaucoma 03/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Leukemia 01/2017
1	Fibrosis (Cirrhosis) 01/2015
1	Liver Diseases (Liver Disease) 01/2015
1	Hyperalgesia 11/2014
1	Epilepsy (Aura) 11/2014
1	Dementia (Dementias) 03/2014
1	Esophageal Neoplasms (Esophageal Cancer) 12/2013
1	Memory Disorders (Memory Loss) 11/2013
1	Alzheimer Disease (Alzheimer's Disease) 11/2013
1	Reperfusion Injury 01/2013
1	Hypoxia (Hypoxemia) 01/2013
1	Brain Ischemia (Cerebral Ischemia) 01/2013
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2013
1	Stroke (Strokes) 01/2013
1	Infarction (Infarctions) 01/2013

Drug/Important Bio-Agent (IBA)

5	amentoflavoneIBA 05/2022 - 09/2017
5	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 02/2012
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2017
3	Pharmaceutical PreparationsIBA 01/2022 - 03/2019
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021 - 01/2018
2	lenvatinibIBA 05/2022 - 01/2022
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 02/2012
2	regorafenibIBA 01/2022 - 01/2018
2	p38 Mitogen-Activated Protein KinasesIBA 01/2022 - 01/2021
2	Neuroprotective AgentsIBA 01/2019 - 01/2013
2	thiazolyl blueIBA 05/2018 - 01/2017
1	Phosphotransferases (Kinase)IBA 01/2022
1	QuinolonesIBA 01/2022
1	NF-kappa B (NF-kB)IBA 01/2022
1	Protein Kinase C-deltaIBA 01/2022
1	Biological ProductsIBA 10/2021
1	Genetic Markers (Genetic Marker)IBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 09/2021
1	DNA TopoisomerasesIBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	Cell Cycle ProteinsIBA 01/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2021
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2021
1	astragaloside AIBA 03/2020
1	Retinaldehyde (Retinal)IBA 03/2019
1	2,3,7,7a- tetrahydro- 3- hydroxy- 7- methyl- 2- (prop- 1- en- 1- yl)- 5H- furo(3,4- b)pyran- 5- oneIBA 03/2019
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 03/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2019
1	CytokinesIBA 03/2019
1	LipopolysaccharidesIBA 01/2019
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 05/2018
1	LuciferasesIBA 01/2018
1	Apoptosis Regulatory ProteinsIBA 01/2018
1	Cyclin D1IBA 01/2017
1	Protein CIBA 01/2017
1	hyperforinIBA 01/2017
1	X-Linked Inhibitor of Apoptosis ProteinIBA 01/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2016
1	Indicators and Reagents (Reagents)IBA 01/2015
1	Carbamazepine (Tegretol)FDA LinkGeneric 11/2014
1	Sevoflurane (Ultane)FDA LinkGeneric 11/2013
1	Anesthetics (Anesthetic Agents)IBA 11/2013
1	TropoloneIBA 01/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2013
1	beta-thujaplicinIBA 01/2013
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2013
1	Caspase 3 (Caspase-3)IBA 01/2013

Therapy/Procedure

8	Radiotherapy 02/2022 - 03/2005
6	Therapeutics 01/2022 - 12/2006
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 12/2013 - 12/2006
2	Chemoradiotherapy 02/2022 - 01/2022
2	Surgical Instruments (Clip) 12/2016 - 04/2014
1	Esophagectomy 01/2022
1	Boron Neutron Capture Therapy 04/2021
1	Image-Guided Radiotherapy 01/2021
1	Adjuvant Radiotherapy 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	General Anesthesia 03/2014
1	Art Therapy 03/2012